The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The impact of CD34+ cell dose and comorbidities on engraftment following autologous hematopoietic stem cell transplantation (ASCT).
Mark A Fiala
No relevant relationships to disclose
Pavan Kumar Bhamidipati
No relevant relationships to disclose
Stephanie Wang
No relevant relationships to disclose
Trisha Sturgill
No relevant relationships to disclose
Feng Gao
No relevant relationships to disclose
Camille N. Abboud
No relevant relationships to disclose
Amanda F. Cashen
No relevant relationships to disclose
Meagan A. Jacoby
No relevant relationships to disclose
Iskra Pusic
No relevant relationships to disclose
Rizwan Romee
No relevant relationships to disclose
Mark A. Schroeder
No relevant relationships to disclose
Geoffrey L. Uy
No relevant relationships to disclose
Ravi Vij
No relevant relationships to disclose
Peter Westervelt
No relevant relationships to disclose
John F. DiPersio
No relevant relationships to disclose
Keith Stockerl-Goldstein
No relevant relationships to disclose